about
C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.Porcine extrahepatic vascular endothelial asialoglycoprotein receptor 1 mediates xenogeneic platelet phagocytosis in vitro and in human-to-pig ex vivo xenoperfusion.Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditionsSurface modification of pig endothelial cells with a branched heparin conjugate improves their compatibility with human blood.Reconstituted high-density lipoprotein modulates activation of human leukocytes.Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium.Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgeryHisto-blood group antigens as allo- and autoantigens.Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in PigsEndothelial cell protection in xenotransplantation: looking after a key player in rejection.AB0 blood group incompatible haematopoietic stem cell transplantation and xenograft rejection.Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation.Intravenous immunoglobulins--understanding properties and mechanisms.Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function.Role of complement and perspectives for intervention in ischemia-reperfusion damage.Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serum.Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.IgM-enriched human introvenous immunoglobulin strongly inhibits complement-dependent porcine cell cytotoxicity mediated by human xenoreactive antibodies.A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft.Regulatory sequences of the porcine THBD gene facilitate endothelial-specific expression of bioactive human thrombomodulin in single- and multitransgenic pigs.Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.siRNA mediated knockdown of tissue factor expression in pigs for xenotransplantation.Organ inflammation in porcine Escherichia coli sepsis is markedly attenuated by combined inhibition of C5 and CD14.Design of the blood group AB glycotope.Immunosuppression in ABO-incompatible transplantation.Normal levels of allo- but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patients.Induction of hypoxia inducible factor 1α by Toll-like receptors in human dendritic cells.Edema is a sign of early acute myocardial infarction on post-mortem magnetic resonance imaging.Dextran sulfate modulates MAP kinase signaling and reduces endothelial injury in a rat aortic clamping model.TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells.Ischemia/reperfusion injury of porcine limbs after extracorporeal perfusion.Transgenic Expression of Human CD46 on Porcine Endothelium: Effect on Coagulation and Fibrinolytic Cascades During Ex Vivo Human-to-Pig Limb Xenoperfusions.Normal human serum contains high levels of anti-Gal alpha 1-4GlcNAc antibodies.The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells.Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate.Inhalation anesthesia of rats: influence of the fraction of inspired oxygen on limb ischemia/reperfusion injury.Activation of the lectin pathway of complement in pig-to-human xenotransplantation models.Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood.Bioengineering a Human Face Graft: The Matrix of Identity.
P50
Q31132259-026967DE-88B7-4539-86E7-791F2B866BFEQ33420349-E79E4FB3-2537-4D0A-AF5D-3C7971514E1CQ33601510-73E931CA-7CF4-49BF-8655-A9DC9960D86EQ33860854-12508C11-15B7-477B-B42D-7BA0904509C3Q34963571-BDE0E40E-FE65-47E5-BC8F-D47A1FF24CD2Q35998264-1D626D5E-8903-4525-B020-490C88A7826EQ36112904-CF8BA6BD-54CC-4541-ADFE-0F68B9859D50Q36193054-7D668D18-48D6-486C-90F3-AAD6BBB57BD0Q36230443-ECF14827-CFEF-4BB2-8E20-55C37E0568BEQ36404498-92318218-CCCF-46F2-A7FF-0C051385DC04Q36735495-305F5461-8C4A-4E65-91D0-6D290ACADB9EQ37250322-60582B87-1DCA-4555-B340-3D336B2A74FEQ37626118-723C698B-2DA1-4ACD-A202-98AC74A9F4C5Q37680021-0C0760CD-5FFC-4C53-A82E-584B431ADDFEQ37831329-B81CA487-FF1F-4F2F-A54F-7325994F8758Q38175226-1961DDAC-7DBB-4655-AC19-AC8D454E9A49Q38301329-1FF31913-B9DC-4460-A7CB-C2AEF91E89E3Q38341553-1A202FE5-22E5-41E6-A326-576F0D2F040CQ38346227-7D4AA56E-A78E-40C8-AFEE-9879619B56F2Q38966155-F8518C04-C3A3-4DBF-BBE8-D08962FD7B91Q39073376-EB776735-DF67-44E0-ACAE-D717D5019D5BQ40590242-F2339ACB-933D-4574-AB2E-6FF2FDCF6F8EQ41161110-429E46D0-E974-497B-BC56-AE4CD709E701Q41247465-27416EB8-5AF9-4CC0-B1EF-B610CFAE239BQ42666294-2805C9E5-9D6C-489F-96D7-252E697E7FA5Q43620740-69405C3C-D091-4311-8227-0AF43A7DCD7CQ43843597-0291FE64-2A5B-4C1F-9A86-9B27E1516617Q45767423-8F2326D9-C6F7-4682-BC88-0C1EBB01AA2FQ45814746-FB815BAA-C709-4065-835E-4949D72EB5DDQ45947659-85E07D17-790C-475A-A4EF-4CDB00E0FDEAQ45950436-5B0BBF66-9DDE-43C6-83C8-10A391AD6EB3Q46220153-6054EE0A-17DB-408F-A5DA-C1ADA2575D5AQ46729989-8453DDCE-EE8D-464E-9BAA-FB1AB6FB3F1DQ46908625-DFB0D3FE-955A-41DD-833B-4F99382DA431Q47226663-C8E2E4D7-62A3-46E3-9C09-09E9368143BFQ47428620-BD823608-A81D-4E2A-B80A-467C69979855Q47655736-B96BEE45-F2E9-4397-9F26-43C44F989B1DQ47745361-9A201926-BEE0-4548-B5B2-C02FD69CBD06Q47772179-87019626-C050-4B96-98EC-345153767A31Q47882087-0561906E-02DD-4FD2-939C-9933AF278FF7
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Robert Rieben
@ast
Robert Rieben
@en
Robert Rieben
@es
Robert Rieben
@nl
Robert Rieben
@sl
type
label
Robert Rieben
@ast
Robert Rieben
@en
Robert Rieben
@es
Robert Rieben
@nl
Robert Rieben
@sl
prefLabel
Robert Rieben
@ast
Robert Rieben
@en
Robert Rieben
@es
Robert Rieben
@nl
Robert Rieben
@sl
P214
P1053
D-7044-2017
P106
P21
P214
P31
P3829
P496
0000-0003-4179-8891
P734
P735
P7859
viaf-220126348